Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
facilities
Pharma
Nektar extends cash runway with $90M manufacturing plant sale
Nektar is selling its Alabama manufacturing plant and reagent supply business to private equity firm Ampersand for a total value of $90 million.
Fraiser Kansteiner
Nov 4, 2024 1:16pm
Vertex adds CDMO Lonza to Casgevy production network
Sep 24, 2024 9:41am
Zydus hit with FDA warning letter flagging glass contamination
Sep 11, 2024 11:42am
CDMO Brassica blasted in 4-observation FDA warning letter
Jul 24, 2024 9:25am
Novo scoops up 200 acres for a potential new production plant
Jul 23, 2024 10:35am
Agilent will pay $925M to acquire specialty CDMO Biovectra
Jul 22, 2024 11:01am